Involvement of cholinergic neurons in orexin-induced contraction of guinea pig ileum

European Journal of Pharmacology

Volumn 452, Issue 1, 2002, Pages 105-109

  Matsuo, Katsuhisa ^a   Kaibara, Muneshige ^a   Uezono, Yasuhito ^a   Hayashi, Hideki ^a   Taniyama, Kohtaro ^a   Nakane, Yoshibumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine release; Orexin 1 receptor; Orexin A; SB 334867 A; Tetrodotoxin

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 1 (2 METHYLBENZOXAZOL 6 YL) 3 [1,5]NAPHTHYRIDIN 4 YLUREA; 8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; ACETYLCHOLINE; ATROPINE; CHOLINE; GRANISETRON; HEXAMETHONIUM; OREXIN A; SEROTONIN ANTAGONIST; TETRODOTOXIN; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; EVOKED RESPONSE; FEMALE; GUINEA PIG; ILEUM CONTRACTION; INCUBATION TIME; MALE; MUSCLE TWITCH; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; ATROPINE; BENZOXAZOLES; CARRIER PROTEINS; ENTERIC NERVOUS SYSTEM; FEMALE; GANGLIONIC BLOCKERS; GUINEA PIGS; HEXAMETHONIUM; ILEUM; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NEURONS; NEUROPEPTIDES; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; TETRODOTOXIN; UREA;

EID: 0037183773     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02300-2     Document Type: Article

References (27)

1. Akehira K., Nakane Y., Hioki K., Taniyama K. Site of action of galanin in the cholinergic transmission of guinea pig small intestine. Eur. J. Pharmacol. 284:1995;149-155.
2. Brown R.E., Sergeeva O., Eriksson K.S., Haas H.L. Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology. 40:2001;457-459.
3. Chemelli R., Willie J., Sinton C., Elmquist J., Scammell T., Lee C., Richardson J., Williams S., Xiong Y., Kisanuki Y., Fitch T., Nakazato M., Hammer R., Saper C., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
4. Cohen M.L., Landry A.S. Vasoactive intestinal polypeptide: increased tone, enhancement of acetylcholine release, and stimulation of adenylate cyclase in intestinal smooth muscle. Life Sci. 26:1980;811-822.
5. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanaagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. U. S. A. 96:1999;748-753.
6. Edwards C.M., Abusnana S., Sunter D., Mutphy K.G., Ghatei M.A., Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 160:1999;R7-R12.
7. Gonella J., Niel J.P., Roman C. Mechanism of the noradrenergic motor control on the lower oesophageal sphincter in the cat. J. Physiol. (Lond.). 306:1980;251-260.
8. Horvath T., Diano S., van den Pol A. Synaptic interaction between hypocretin orexin and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 19:1999;1072-1087.
9. Ida T., Nakahara K., Nakahara K., Katayama T., Murakami N., Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 821:1999;526-529.
10. Kan S., Niwa M., Taniyama K. Specific receptor for vasoactive intestinal contractor in myenteric cholinergic neurons. Eur. J. Pharmacol. 258:1994;139-143.
11. Kirchgessner A.L., Liu M.-T. Orexin synthesis and response in the gut. Neuron. 24:1999;941-951.
12. Kusunoki M., Tsai L.H., Taniyama K., Tanaka C. Vasoactive intestinal polypeptide provokes acetylcholine release from the myenteric plexus. Am. J. Physiol. 251:1986;G51-G55. (Gastrointest. Liver Physiol. 14).
13. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qin X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
14. López M., Senaris R., Gallego R., Garcia-Caballero T., Lago F., Seoane L., Casanueva F., Dieguez C. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology. 140:1999;5991-5994.
15. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260.
16. Peyron C., Tighe D., van den Pol A., de Lecea L., Heller H., Sutcliffe J., Kilduff T. Neurons hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18:1998;9996-10015.
17. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R., Tanaka H., Williams S., Richardson J., Kozlowski G., Wilson S., Arch J., Buckingham R.E., Haynes A., Carr S., Annan R., MacNutty D., Li W., Terrett J., Elshourbagy N., Bergsma D., Yanagisawa M. Orexins and orexins receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviour. Cell. 92:1998;573-585.
18. Sawa T., Mameya S., Yoshimura M., Itsuno M., Makiyama K., Niwa M., Taniyama K. Differential mechanism of peptide YY and neuropeptide Y in inhibiting motility of guinea-pig colon. Eur. J. Pharmacol. 1995;223-230.
19. Smart D., Sabido-David C., Brough S.J., Jewitt F., Johns A., Porter R.A., Jerman J.C. SB-334867-A: the first selective orexin-1 receptor antagonist. Br. J. Pharmacol. 132:2001;1179-1182.
20. Soffin E.M., Evans M.L., Gill C.H., Harries M.H., Benham C.D., Davies C.H. SB-334867-A antagonizes orexin mediated excitation in the locus coeruleus. Neuropharmacology. 42:2002;127-133.
21. Starke K. Presynaptic receptors. Annu. Rev. Pharmacol. Toxicol. 21:1981;7-30.
22. Sweet D.C., Levine A.S., Billington C.J., Kotz C.M. Feeding response to central orexins. Brain Res. 821:1999;535-538.
23. Taniyama K., Makimoto N., Furuichi A., Sakurai-Yamashita Y., Nagase Y., Kaibara M., Kanematsu T. Functions of peripheral 5-hydroxytryptamine receptors, especially 5-hydroxytryptamine4 receptor, in gastrointestinal motility. J. Gastroenterol. 35:2000;575-582.
24. van den Pol A. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J. Neurosci. 19:1999;3171-3182.
25. Vizi E.S., Bertaccini G., Impicciatore M., Knoll J. Evidence that acetylcholine release by gastrin and related polypeptides contributes to their effects on gastrointestinal motility. Gastroenterology. 64:1973;268-277.
26. Vizi E.S., Ono K., Adam-Vizi V., Duncalf D., Foldes F. Presynaptic inhibitory effect of Met-enkephalin on [14C]acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition. J. Pharmacol. Exp. Ther. 230:1984;493-499.
27. Willie J.T., Chemelli R.M., Sinton C.M., Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24:2001;429-458.